We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
-1.68%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$688M
AUM Growth
-$29.1M
Cap. Flow
+$6.68M
Cap. Flow %
0.97%
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
3
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
IMDX
Insight Molecular Diagnostics
IMDX
+$13.1M
2
AXON
Axon Enterprise
AXON
+$11.5M

Top Sells

Rank Stock Value
1
MNST icon
Monster Beverage
MNST
+$1.48M

Sector Composition

Rank Sector Weight
1 Consumer Staples 39.68%
2 Healthcare 38.48%
3 Industrials 4.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNST icon
1
Monster Beverage
MNST
$94.3B
$273M 39.68%
9,547,416
-47,400
-0.5% -$1.48M
STAA icon
2
STAAR Surgical
STAA
$1.21B
$161M 23.34%
10,855,179
– –
LCTX icon
3
Lineage Cell Therapeutics
LCTX
$269M
$80.6M 11.71%
34,257,494
– –
IWM icon
4
iShares Russell 2000 ETF
IWM
$79.8B
$63.8M 9.26%
420,000
– –
MNST icon
5
PUT
Monster Beverage
MNST
$94.3B
$45.8M 6.65%
1,600,000
+600,000
+60% +$18.7M
AXON
6
Axon Enterprise
AXON
$42.5B
$29.9M 4.34%
760,062
+368,970
+94% +$11.5M
IMDX
7
Insight Molecular Diagnostics
IMDX
$150M
$15.9M 2.31%
378,247
+198,413
+110% +$13.1M
DAL icon
8
PUT
Delta Air Lines
DAL
$57.5B
$11M 1.59%
200,000
-50,000
-20% -$2.76M
AST
9
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$7.67M 1.11%
5,292,156
– –
BA icon
10
PUT
Boeing
BA
$171B
– –
-110,000
Closed -$32.4M

Similar funds

PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.41B AUM 18.71% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return

Broadwood Capital's Q1 2018 Portfolio in Review

As of Q1 2018, Broadwood Capital held 10 positions worth $688M, down 4.1% from $717M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Broadwood Capital's Q1 2018 filing shows 3 increased, 2 reduced and 1 closed positions. The largest sale was Monster Beverage, an estimated $1.48M.

By sector, the portfolio is most concentrated in Consumer Staples at 40% of assets, down from 42% a quarter earlier, followed by Healthcare and Industrials.

  • Broadwood Capital added most to Insight Molecular Diagnostics in Q1 2018, an estimated $13.1M increase.
  • Broadwood Capital's biggest Q1 2018 reduction was Monster Beverage, cutting an estimated $1.48M.
  • Broadwood Capital's ten largest holdings make up 100% of its $688M portfolio in Q1 2018.
  • Broadwood Capital opened 0 new positions and closed 1 in Q1 2018.
  • Broadwood Capital's portfolio value fell 4.1% quarter-over-quarter to $688M.

Based on Broadwood Capital's 13F filing for Q1 2018, filed 15 May 2018.